RARE logo

Ultragenyx Pharmaceutical Inc. (RARE) Net Margin

Annual Net Margin:

-101.60%+38.10%(+27.27%)
December 31, 2024

Summary

  • As of today, RARE annual net profit margin is -101.60%, with the most recent change of +38.10% (+27.27%) on December 31, 2024.
  • During the last 3 years, RARE annual net margin has risen by +27.60% (+21.36%).
  • RARE annual net margin is now -47.59% below its all-time high of -68.84%, reached on December 31, 2020.

Performance

RARE Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRAREprofitability metrics

Quarterly Net Margin:

-69.04%+39.42%(+36.35%)
June 30, 2025

Summary

  • As of today, RARE quarterly net profit margin is -69.04%, with the most recent change of +39.42% (+36.35%) on June 30, 2025.
  • Over the past year, RARE quarterly net margin has increased by +20.47% (+22.87%).
  • RARE quarterly net margin is now -268.31% below its all-time high of 41.02%, reached on June 30, 2020.

Performance

RARE Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRAREprofitability metrics

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

RARE Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+27.3%+22.9%
3Y3 Years+21.4%+61.0%
5Y5 Years+73.8%-268.3%

RARE Net Margin Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+47.8%at high+74.5%
5Y5-Year-47.6%+73.8%-163.2%+74.5%
All-TimeAll-Time-47.6%+100.0%-268.3%+100.0%

RARE Net Margin History

DateAnnualQuarterly
Jun 2025
-
-69.04%(+36.3%)
Mar 2025
-
-108.46%(-34.1%)
Dec 2024
-101.60%(+27.3%)
-80.90%(+15.5%)
Sep 2024
-
-95.71%(-6.9%)
Jun 2024
-
-89.51%(+42.9%)
Mar 2024
-
-156.83%(-62.2%)
Dec 2023
-139.70%(+28.3%)
-96.70%(+40.6%)
Sep 2023
-
-162.82%(-10.3%)
Jun 2023
-
-147.57%(+9.6%)
Mar 2023
-
-163.16%(-11.1%)
Dec 2022
-194.71%(-50.7%)
-146.91%(+45.6%)
Sep 2022
-
-270.23%(-52.6%)
Jun 2022
-
-177.03%(+7.1%)
Mar 2022
-
-190.55%(-29.8%)
Dec 2021
-129.20%
-146.85%(-64.2%)
Sep 2021
-
-89.41%(+36.5%)
Jun 2021
-
-140.76%(-2.8%)
DateAnnualQuarterly
Mar 2021
-
-136.97%(-422.2%)
Dec 2020
-68.84%(+82.3%)
-26.23%(+69.0%)
Sep 2020
-
-84.50%(-306.0%)
Jun 2020
-
41.02%(+112.5%)
Mar 2020
-
-327.81%(-24.4%)
Dec 2019
-388.31%(-1.2%)
-263.55%(+39.8%)
Sep 2019
-
-437.96%(-6.6%)
Jun 2019
-
-410.67%(+22.9%)
Mar 2019
-
-532.45%(+1.4%)
Dec 2018
-383.75%(+96.7%)
-540.10%(+27.2%)
Sep 2018
-
-742.24%(-80.1%)
Jun 2018
-
-412.13%(+87.8%)
Dec 2017
-11.57K%(+93.7%)
-3385.71%(+91.5%)
Sep 2017
-
-40.01K%(+97.2%)
Dec 2016
-184.87K%
-1.43M%(-2338.2%)
Sep 2016
-
-58.47K%(+82.5%)
Jun 2016
-
-334.84K%

FAQ

  • What is Ultragenyx Pharmaceutical Inc. annual net profit margin?
  • What is the all-time high annual net margin for Ultragenyx Pharmaceutical Inc.?
  • What is Ultragenyx Pharmaceutical Inc. annual net margin year-on-year change?
  • What is Ultragenyx Pharmaceutical Inc. quarterly net profit margin?
  • What is the all-time high quarterly net margin for Ultragenyx Pharmaceutical Inc.?
  • What is Ultragenyx Pharmaceutical Inc. quarterly net margin year-on-year change?

What is Ultragenyx Pharmaceutical Inc. annual net profit margin?

The current annual net margin of RARE is -101.60%

What is the all-time high annual net margin for Ultragenyx Pharmaceutical Inc.?

Ultragenyx Pharmaceutical Inc. all-time high annual net profit margin is -68.84%

What is Ultragenyx Pharmaceutical Inc. annual net margin year-on-year change?

Over the past year, RARE annual net profit margin has changed by +38.10% (+27.27%)

What is Ultragenyx Pharmaceutical Inc. quarterly net profit margin?

The current quarterly net margin of RARE is -69.04%

What is the all-time high quarterly net margin for Ultragenyx Pharmaceutical Inc.?

Ultragenyx Pharmaceutical Inc. all-time high quarterly net profit margin is 41.02%

What is Ultragenyx Pharmaceutical Inc. quarterly net margin year-on-year change?

Over the past year, RARE quarterly net profit margin has changed by +20.47% (+22.87%)
On this page